InsiderTrades

Form 4 for KNSA Kiniksa Pharmaceuticals International, plc

Accepted 2023-03-20 00:00:00 ET · period of report 2023-03-16 · accession 0001415889-23-005230 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-20 2023-03-16+ KNSA Ragosa Mark CFO M - OptEx — +3,030 10.4K +41% —
DM 2023-03-20 2023-03-16+ KNSA Ragosa Mark CFO F - Tax $11.22 -890 9,811 -8% -$9,984
DM 2023-03-20 2023-03-16+ KNSA Ragosa Mark CFO M - OptEx $0.00 -3,030 1,744 -63% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Share 2023-03-16 M A 872 — 8,543 D — — (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
2 Common Class A Common Share 2023-03-16 F D 256 $11.46 8,287 D — —
3 Common Class A Common Share 2023-03-20 F D 634 $11.12 9,811 D — —
4 Common Class A Common Share 2023-03-20 M A 2,158 — 10,445 D — — (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
5 Derivative Restricted Share Unit 2023-03-20 M D 2,158 $0.00 0 D — · — to — 2,158 Class A Common Share (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F3) The performance criteria for these RSUs were met. The RSUs vested in a single installment on March 20, 2023; there was no expiration date for the RSUs.
6 Derivative Restricted Share Unit 2023-03-16 M D 872 $0.00 1,744 D — · — to — 872 Class A Common Share (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F2) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021.